People · Operator
Named in public records as an officer, director or promoter · active 2012–2013 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Allozyne Inc | — | Biotechnology | Seed | $8.2M | $108.9M | 2012 |
Kenneth Grabstein at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Kenneth Grabstein on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Steven Gillis | 1 | 23 |
| Carl Weissman | 1 | 8 |
| Michael Steinmetz | 1 | 4 |
| John Bencich | 1 | 3 |
| Meenu Chhabra | 1 | 2 |
| David Tirrell | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.